This free sheet contains 100 accelerators and incubators you can apply to today, along with information about the industries they generally invest in.
This free sheet contains all the information about the top 100 unicorns, including their valuation, HQ's location, founded year, name of founders, funding amount and number of employees.
This free Notion document contains the best 100+ resources you need for building a successful startup, divided in 4 categories: Fundraising, People, Product, and Growth.
The health diagnostics sector is seeing major growth, driven by advances in artificial intelligence and biotechnology. Companies are developing new ways to monitor health and detect diseases earlier.
This includes startups like Freenome, which has raised $1.5 billion for its cancer detection blood tests. Others, like the recently founded Doctronic, are using AI to provide instant medical guidance.
Below is our list of 100 Health Diagnostics startups worth keeping an eye on.
Everything you need to raise funding for your startup, including 3,500+ investors, 7 tools, 18 templates and 3 learning resources.
Buy It For $97 $297 →Information about the industries, countries, and cities they generally invest in.
Get the Sheet for $50Information about their valuation, HQ's location, founded year, name of founders, funding amount and number of employees.
Get the Sheet for $50List of startup investors in the BioTech, Health, and Medicine industries, along with their Twitter, LinkedIn, and email addresses.
Get the Sheet for $50List of 250 startup investors in the AI and Machine Learning industries, along with their Twitter, LinkedIn, and email addresses.
Get the Sheet for $50List of 250 startup investors in the FinTech and Finance industries, along with their Twitter, LinkedIn, and email addresses.
Get the Sheet for $50Doctronic builds an AI-driven platform that delivers instant and secure medical guidance. The service provides seamless 24/7 access to licensed physicians for further consultation and care.
Hormona created a health platform that uses AI and at-home testing to help women track and manage their hormonal health. Their app provides personalized insights and guidance to help users understand their body's unique hormonal patterns.
Character Biosciences built a platform that integrates genomics, clinical data, and AI to create a deeper understanding of human diseases. They use this technology to discover and develop novel therapeutics, starting with treatments for age-related macular degeneration.
Element Biosciences creates advanced genetic analysis tools for the life sciences industry. Their AVITI System provides researchers with a powerful and cost-effective benchtop platform for DNA sequencing.
Function Health has built a health platform that provides members with access to over 100 lab tests for a complete look inside their bodies. The service delivers ongoing health insights, helping people shift from reactive treatment to proactive health management.
Pearl creates AI-powered software to advance the quality of dental care for clinics and their patients. The company's core technology provides real-time disease detection in x-rays and offers insights to improve a practice's overall performance.
Fountain Life has developed a preventative health platform that uses AI-powered screenings to detect potential illnesses early. Based on these diagnostics, they create personalized wellness programs for members focused on longevity and peak performance.
Notable created an AI platform that automates administrative and clinical workflows for healthcare organizations. This intelligent automation platform handles everything from patient intake to billing, freeing up staff to concentrate on patient care.
meQuilibrium offers a digital platform that provides stress management and resilience-building solutions for employees. Their software uses data analytics and behavioral science to deliver personalized programs aimed at improving workforce well-being.
Freenome creates blood tests that can detect cancer in its earliest stages. The biotechnology company's multiomics platform is designed to make routine screening more accessible by analyzing a simple blood draw for cancer signals.
Our top 10 picks are just a small slice of the exciting work happening in health diagnostics. Many of the most promising new companies are using AI and biotechnology to find new ways of understanding our health.
Together, these startups have raised billions of dollars, with some just starting out and others scaling quickly. Here is a look at the other 90 companies that are reshaping the future of health.
| Startup | Main Industry | Year Founded | Amount Raised | Last Funding Round |
|---|---|---|---|---|
| Healthcare | 2022 | $34M | Series A | |
| Biotech | 2016 | $425.9M | Series D | |
| AI | 2017 | $59.2M | Venture Round | |
| Healthcare | 2015 | $49.5M | Venture Round | |
| AI | 2018 | $130.6M | Series C | |
| Biotech | 2023 | $28.6M | Series A | |
| Biotech | 2004 | $22.7M | Grant | |
| AI | 2021 | $29.9M | Series A | |
| Healthcare | 2014 | $227M | Series D | |
| Biotech | 2021 | $3B | Series A | |
| AI | 2016 | $125.3M | Series D | |
| Biotech | 2013 | $369.8M | Series B | |
| Healthcare | 2020 | $21.5M | Seed | |
| Biotech | 2020 | $59.2M | Series A | |
| Fashion | 2021 | $2M | Grant | |
| AI | 2018 | $99M | Series C | |
| AI | 2017 | $113.8M | Series C | |
| Healthcare | 2019 | $64.9M | Series B | |
| Healthcare | 2019 | $16.6M | Series A | |
| Biotech | 2007 | $85.7M | Corporate Round | |
| Healthcare | 2019 | $10M | Venture Round | |
| Biotech | 2015 | $217.9M | Series C | |
| Biotech | 2006 | $16.3M | Convertible Note | |
| Marketing | 2016 | $95.1M | Venture Round | |
| Healthcare | 2016 | $36.1M | Venture Round | |
| AI | 2017 | $84.9M | Debt Financing | |
| Healthcare | 2017 | $53.5M | Series C | |
| Healthcare | 2011 | CN¥3.3B | Series A | |
| AI | 2019 | $30.9M | Series A | |
| Biotech | 2013 | $115M | Series C | |
| Biotech | 2016 | $194.8M | Series E | |
| Biotech | 2017 | $5.6M | Debt Financing | |
| Biotech | 2018 | $30.1M | Venture Round | |
| Biotech | 2014 | $142.1M | Series C | |
| AI | 2018 | $5.2M | Grant | |
| Healthcare | 2019 | $203M | Debt Financing | |
| Biotech | 2018 | $220M | Series C | |
| AI | 2023 | $2.3M | Pre-Seed | |
| Healthcare | 2012 | $19.5M | Private Equity | |
| AI | 2014 | $156.5M | Series D | |
| AI | 2013 | $228.6M | Venture Round | |
| AI | 2021 | $5.8M | Series A | |
| AI | 2022 | $30M | Series A | |
| Biotech | 2021 | $56M | Series A | |
| Media | 2016 | $12.3M | Debt Financing | |
| Healthcare | 2016 | $465.1M | Series E | |
| AI | 2015 | $125.1M | Series D | |
| Healthcare | 2012 | $435.8M | Venture Round | |
| Biotech | 2017 | $33.5M | Undisclosed | |
| Biotech | 2017 | $43.6M | Series A | |
| Analytics | 2012 | $31M | Series B | |
| Healthcare | 2019 | $77.3M | Series B | |
| Healthcare | 2019 | $10.8M | Debt Financing | |
| AI | 2018 | $101.7M | Series B | |
| AI | 2012 | $69.6M | Series A | |
| Biotech | 2011 | CHF172M | Series C | |
| Biotech | 2013 | $233M | Series E | |
| Healthcare | 2021 | $25.6M | Series A | |
| Healthcare | 2018 | CHF84M | Series B | |
| Biotech | 2020 | $3.4M | Grant | |
| AI | 2013 | $26.1M | Series B | |
| Healthcare | — | ₹9.4B | Private Equity | |
| Biotech | 2017 | $36M | Venture Round | |
| Healthcare | 2020 | $25.8M | Series A | |
| AI | 2014 | $35.4M | Grant | |
| Healthcare | 2008 | $228.2M | Series D | |
| Analytics | 2022 | $2.9M | Pre-Seed | |
| AI | 2018 | $54.8M | Series B | |
| Enterprise | 2018 | $130.7M | Series B | |
| Biotech | 2000 | $117.5M | Venture Round | |
| Healthcare | 2018 | $15M | Venture Round | |
| Healthcare | 2009 | $215.5M | Secondary Market | |
| Biotech | 2016 | $24.4M | Venture Round | |
| Biotech | 2009 | $11M | Corporate Round | |
| AI | 2021 | €12.4M | Seed | |
| Healthcare | 2020 | $70.9M | Series A | |
| Healthcare | 2018 | $151.9M | Series C | |
| Healthcare | 2015 | $17M | Venture Round | |
| AI | 2018 | $2.9M | Venture Round | |
| Healthcare | 2020 | $6.2M | Seed | |
| Healthcare | 2017 | CN¥1B | Series A | |
| Healthcare | 2020 | $46.9M | Venture Round | |
| Biotech | 2004 | SEK90M | Series A | |
| Biotech | 2014 | $136.5M | Series D | |
| Biotech | 1996 | ₹1.5B | Debt Financing | |
| Healthcare | 2019 | €10M | Private Equity | |
| AI | 2015 | $36.8M | Venture Round | |
| AI | 2022 | €529.7k | Convertible Note | |
| AI | 2016 | CHF15.1M | Series B | |
| Healthcare | 2020 | $100M | Series A |
